Adolphe Merkle Institute, University of Fribourg, Fribourg, Switzerland.
Comprehensive Molecular Analytics, Helmholtz Center Munich, Munich, Germany.
Methods Mol Biol. 2020;2140:199-215. doi: 10.1007/978-1-0716-0520-2_13.
Increasing ethical and biological concerns require a paradigm shift toward animal-free testing strategies for drug testing and hazard assessments. To this end, the application of bioprinting technology in the field of biomedicine is driving a rapid progress in tissue engineering. In particular, standardized and reproducible in vitro models produced by three-dimensional (3D) bioprinting technique represent a possible alternative to animal models, enabling in vitro studies relevant to in vivo conditions. The innovative approach of 3D bioprinting allows a spatially controlled deposition of cells and biomaterial in a layer-by-layer fashion providing a platform for engineering reproducible models. However, despite the promising and revolutionizing character of 3D bioprinting technology, standardized protocols providing detailed instructions are lacking. Here, we provide a protocol for the automatized printing of simple alveolar, bronchial, and intestine epithelial cell layers as the basis for more complex respiratory and gastrointestinal tissue models. Such systems will be useful for high-throughput toxicity screening and drug efficacy evaluation.
日益增长的伦理和生物学问题需要向无动物测试策略转变,以用于药物测试和危害评估。为此,生物打印技术在生物医学领域的应用正在推动组织工程的快速发展。特别是,三维(3D)生物打印技术产生的标准化和可重复的体外模型可能是动物模型的替代方法,使体外研究与体内条件相关。3D 生物打印的创新方法允许以空间控制的方式将细胞和生物材料分层沉积,为工程可重复模型提供了一个平台。然而,尽管 3D 生物打印技术具有很有前景和变革性的特点,但缺乏提供详细说明的标准化方案。在这里,我们提供了一个简单的肺泡、支气管和肠上皮细胞层的自动打印方案,作为更复杂的呼吸和胃肠道组织模型的基础。此类系统将有助于高通量毒性筛选和药物功效评估。